The notices it replaced
- Reissues: RFA-AI-18-036 Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
- 2 steps back: RFA-AI-12-019 Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1)
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,943,650 in first-year total cost, median $14,943,650.
Most frequent study sections
- Special Emphasis Panel[ZAI1 BLG-M (S1)]1
Most frequent institutions
- DUKE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Antibacterial Resistance Leadership Group (ARLG)2UM1AI104681-08 · under RFA-AI-18-036 | FOWLER, VANCE G.HENRY CHAMBERS, HENRY F | DUKE UNIVERSITY, NC | $14,943,650 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.